Geron Corp (GERN)
3.765
+0.10
(+2.87%)
USD |
NASDAQ |
Nov 18, 16:00
3.765
0.00 (0.00%)
After-Hours: 20:00
Geron Gross Profit Margin (Quarterly): 98.39% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.39% |
| Date | Value |
|---|---|
| June 30, 2024 | 98.07% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
98.07%
Minimum
Jun 2024
98.39%
Maximum
Sep 2024
98.23%
Average
98.23%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 56.80% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -67.86% |
| Return on Assets | -46.07% |
| Return on Invested Capital | -53.90% |
| Profit Margin (Quarterly) | -93.55% |
| Operating Margin (Quarterly) | -99.80% |
| Return on Net Operating Assets | -1.04K% |